Learn more about ZELSUVMI

Sign up to receive more information and updates about ZELSUVMI.

This program is intended for US residents only.

*Required fields

We’ll only use this to send you the communications you’ve requested.

We’re committed to understanding the impact of ZELSUVMI and helping others on their treatment journey. Would you be willing to share your experience with us? Your insights could help improve ZELSUVMI and provide valuable support to others facing molluscum contagiosum.

For California Residents: By completing this form and submitting it for the purposes of receiving information and updates about ZELSUVMI, you understand that Pelthos Therapeutics may collect and use your Personal Information for the business purposes noted in Pelthos Therapeutics' California Notice at Collection located at https://pelthos.com/privacy-policy/. To opt-out of the use of this Personal Information, you may email us at contact@pelthos.com or contact us via phone at 1-919-908-2400. Only you, or someone legally authorized to act on your behalf, may make an opt-out request.

Thank you for registering!

Return to Home

What is ZELSUVMI?

ZELSUVMI is prescription medicine used on the skin (topical) to treat molluscum contagiosum in adults and children 1 year of age and older. It is not known if ZELSUVMI is safe and effective in children under 1 year of age.

IMPORTANT SAFETY INFORMATION

What warnings should I know about ZELSUVMI?

ZELSUVMI is for use on the skin (for topical use) only. Do not use ZELSUVMI near or in your eyes, mouth, or vagina.

ZELSUVMI may cause serious side effects, including:

  • Application site reactions. Application site reactions, including allergic skin reactions, are common where ZELSUVMI is applied to your skin, but can also be severe. Stop using ZELSUVMI and tell your healthcare provider right away if you develop pain, burning, stinging, itching, swelling, or redness of your skin that lasts for more than 24 hours after treatment with ZELSUVMI.

Before using ZELSUVMI, tell your healthcare provider about all your medical conditions, including if you:

  • Have other skin problems.
  • Are pregnant or plan to become pregnant. It is not known if ZELSUVMI will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if ZELSUVMI passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with ZELSUVMI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Keep ZELSUVMI and all medicines out of the reach of children.

What are the possible side effects of ZELSUVMI?

The most common side effects are application site reactions, including pain, burning, stinging, redness, itching, peeling or flaking, itchy dry skin rash, swelling, breakdown of the outer layer of the skin (erosion), lightening or darkening of the skin, blisters, irritation, and infection. These are not all of the possible side effects of ZELSUVMI.

You are encouraged to report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. You may also report side effects and product complaints to Pelthos Inc. by calling 1-855-330-7546.

Please see the full Prescribing Information, Patient Information, and Instructions for Use for ZELSUVMI.

What is ZELSUVMI?

ZELSUVMI is prescription medicine used on the skin (topical) to treat molluscum contagiosum in adults and children 1 year of age and older. It is not known if ZELSUVMI is safe and effective in children under 1 year of age.

IMPORTANT SAFETY INFORMATION

What warnings should I know about ZELSUVMI?

ZELSUVMI is for use on the skin (for topical use) only. Do not use ZELSUVMI near or in your eyes, mouth, or vagina.

ZELSUVMI may cause serious side effects, including:

  • Application site reactions. Application site reactions, including allergic skin reactions, are common where ZELSUVMI is applied to your skin, but can also be severe. Stop using ZELSUVMI and tell your healthcare provider right away if you develop pain, burning, stinging, itching, swelling, or redness of your skin that lasts for more than 24 hours after treatment with ZELSUVMI.